The RD Fund (Retinal Degeneration Fund), which is the venture arm of the Foundation Fighting Blindness, is among the investors in a $78 million venture funding round for California-based Perceive Biotherapeutics.
Read More
Impact investing is on the rise, and local pharmaceutical industry insiders say it’s already paying off. Here’s a look at a growing trend in the search for cures.
Read More
RALEIGH – Opus Genetics recently announced it would open its third preclinical trial, just a few months after the company formed with a $19 million seed financing round led by the venture capital arm of the Foundation Fighting Blindness, the RD Fund. The company, founded by the RD Fund, also...
Read More
With $19 million in seed funding, newly formed Raleigh company Opus Genetics seeks to develop gene therapies to enable vision for patients who inherited blindness.
Read More
